Figure 2

Concentrations of (a) oestradiol (b) progesterone, (c) left and (d) right ovarian volume, (e) hematocrit, and (f) white blood cells during the monitoring period. Asterisks depict statistically significant difference compared to day 5 (*P < 0.001). Oocyte retrieval was performed on day 0. GnRH antagonist was administered from day 5 until and including day 8 post oocyte retrieval, as indicated by arrows.